These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31713331)

  • 41. A rare case of Guillain-Barre syndrome with pregnancy.
    Vijayaraghavan J; Vasudevan D; Sadique N; Rajeswari KS; Pondurangi M; Jayshree
    J Indian Med Assoc; 2006 May; 104(5):269-70. PubMed ID: 17058576
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Present status of high-dose intravenous immunoglobulin therapy and the future prospects ].
    Kawasugi K
    Nihon Rinsho Meneki Gakkai Kaishi; 2003 Jun; 26(3):87-95. PubMed ID: 12868126
    [No Abstract]   [Full Text] [Related]  

  • 43. Venous and arterial thrombosis following administration of intravenous immunoglobulins: reply to Feuillet and colleagues.
    Ben-Ami R; Paran D; Herishanu Y; Elkayam O; Shopin L
    Blood Coagul Fibrinolysis; 2005 Nov; 16(8):619. PubMed ID: 16269938
    [No Abstract]   [Full Text] [Related]  

  • 44. Respiratory distress.
    Kannikeswaran N; Mahajan PV
    Clin Pediatr (Phila); 2005 Apr; 44(3):275-8. PubMed ID: 15821856
    [No Abstract]   [Full Text] [Related]  

  • 45. Parechovirus infection preceding Guillain-Barré syndrome.
    Linden S; Vuorinen T; Österback R; Soilu-Hänninen M
    J Neurovirol; 2012 Oct; 18(5):434-6. PubMed ID: 22581426
    [No Abstract]   [Full Text] [Related]  

  • 46. Should cisapride be avoided in patients with diabetic gastroparesis?
    Evans AJ; Krentz AJ
    J Diabetes Complications; 1999; 13(5-6):314-5. PubMed ID: 10765008
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharyngeal-cervical-brachial variant of pediatric Guillain-Barré syndrome with antecedent acute hepatitis A virus infection.
    Thapa R; Biswas B; Mallick D; Mukherjee S
    J Child Neurol; 2009 Jul; 24(7):865-7. PubMed ID: 19295182
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adverse effect of polyvalent immunoglobulin in the treatment of Guillain-Barre syndrome.
    Chamouni P; Tamion F; Gueit I; Girault C; Lenain P; Varin R; Czernichow P
    Transfus Apher Sci; 2003 Apr; 28(2):117-24. PubMed ID: 12679114
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and cost effectiveness of current therapies in Guillain Barre syndrome.
    Mehndiratta MM; Chowdhury D; Goel V
    J Assoc Physicians India; 2001 Apr; 49():459-69. PubMed ID: 11762620
    [No Abstract]   [Full Text] [Related]  

  • 50. [An elderly case of Guillain-Barré syndrome with anti-GT1b antibodies].
    Kinboshi M; Morimoto Y; Yoshida T; Kuzume D; Yamasaki M
    Rinsho Shinkeigaku; 2019 Sep; 59(9):600-603. PubMed ID: 31474642
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Safety and efficacy of ghrelin agonist TZP-101 in relieving symptoms in patients with diabetic gastroparesis: a randomized, placebo-controlled study.
    Ejskjaer N; Dimcevski G; Wo J; Hellström PM; Gormsen LC; Sarosiek I; Søfteland E; Nowak T; Pezzullo JC; Shaughnessy L; Kosutic G; McCallum R
    Neurogastroenterol Motil; 2010 Oct; 22(10):1069-e281. PubMed ID: 20524987
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A toddler with stridor and leg weakness.
    Godiwala N; Steele RW
    Clin Pediatr (Phila); 2010 Aug; 49(8):809-11. PubMed ID: 20651258
    [No Abstract]   [Full Text] [Related]  

  • 53. Episodes of Guillain-Barré syndrome associated with the acute phase of HIV-1 infection and with recurrence of viremia.
    de Castro G; Bastos PG; Martinez R; de Castro Figueiredo JF
    Arq Neuropsiquiatr; 2006 Sep; 64(3A):606-8. PubMed ID: 17119803
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Complications of Immunoglobulin Therapy and Implications for Treatment of Inflammatory Neuropathy: A Review.
    Abbas A; Rajabally YA
    Curr Drug Saf; 2019; 14(1):3-13. PubMed ID: 30332974
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Blockade of blocking antibodies in Guillain-Barré syndromes: "unblocking" the mystery of action of intravenous immunoglobulin.
    Dalakas MC
    Ann Neurol; 2002 Jun; 51(6):667-9. PubMed ID: 12112069
    [No Abstract]   [Full Text] [Related]  

  • 56. High-dose intravenous immunoglobulin therapy in dysimmune neuropathies.
    Nobile-Orazio E; Bersano A
    Neurol Sci; 2002 Apr; 23 Suppl 1():S25-32. PubMed ID: 12032584
    [No Abstract]   [Full Text] [Related]  

  • 57. Intravenous immunoglobulin and Guillain-Barré syndrome.
    Harel M; Shoenfeld Y
    Clin Rev Allergy Immunol; 2005 Dec; 29(3):281-7. PubMed ID: 16391403
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Guillain-Barré syndrome.
    Ansar V; Valadi N
    Prim Care; 2015 Jun; 42(2):189-93. PubMed ID: 25979580
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Possible association of Guillain-Barré syndrome and hepatitis A vaccination.
    Blumenthal D; Prais D; Bron-Harlev E; Amir J
    Pediatr Infect Dis J; 2004 Jun; 23(6):586-8. PubMed ID: 15194849
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Guillain-Barré syndrome.
    Crawford D; Dearmun A
    Nurs Child Young People; 2017 Mar; 29(2):17. PubMed ID: 28262071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.